{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:32:58Z","timestamp":1793017978954,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Informatics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijmedinf.2025.105916","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T11:12:39Z","timestamp":1745061159000},"page":"105916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Interpretable machine learning model for prediction functional cure in chronic hepatitis B patients receiving Peg-IFN therapy: A multi-center study"],"prefix":"10.1016","volume":"201","author":[{"given":"Peiyu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmedinf.2025.105916_b0005","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Sheena","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0010","unstructured":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021 https:\/\/www.who.int\/publications\/i\/item\/9789240027077."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s12072-022-10400-0","article-title":"New progress towards elimination of mother-to-child transmission of hepatitis B virus in China","volume":"16","author":"Zheng","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0020","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/liv.15959","article-title":"Survey of hepatitis B virus infection status after 35\u2009years of universal vaccination implementation in Taiwan","volume":"44","author":"Chang","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0025","first-page":"1693","article-title":"The expert consensus on clinical cure (functional cure) of chronic hepatitis B","volume":"35","author":"Chinese Society of Infectious Disease","year":"2019","journal-title":"J Clin Hepatol"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2019.11.003","article-title":"Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference\u2021","volume":"72","author":"Cornberg","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0035","first-page":"1309","article-title":"Guidelines for the prevention and treatment of chronic hepatitis b (version 2022)","volume":"30","author":"Chinese Society of Hepatology","year":"2022","journal-title":"Zhonghua GanZang Bing Za Zhi"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733364","article-title":"Interferon and Hepatitis B: Current and Future Perspectives","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0045","article-title":"Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-\u03b1 in NAs-suppressed chronic hepatitis B patients","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1028921","article-title":"Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12985-023-02119-7","article-title":"Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-\u03b1 therapy","volume":"20","author":"Luo","year":"2023","journal-title":"Virol J"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jinf.2023.07.006","article-title":"Artificial intelligence, machine learning and deep learning: Potential resources for the infection clinician","volume":"87","author":"Theodosiou","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1208\/s12248-021-00644-3","article-title":"Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review","volume":"24","author":"Kolluri","year":"2022","journal-title":"AAPS J"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24667","article-title":"Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-\u03b1 monotherapy","volume":"36","author":"Shang","year":"2022","journal-title":"Clin. Lab. Anal."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2024.105660","article-title":"Machine learning models to further identify advantaged populations that can achieve functional cure of chronic hepatitis B virus infection after receiving Peg-IFN alpha treatment","volume":"193","author":"Zhong","year":"2025","journal-title":"Int. J. Med. Inf."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12985-024-02599-1","article-title":"A predictive model for functional cure in chronic HBV patients treated with pegylated interferon alpha: a comparative study of multiple algorithms based on clinical data","volume":"21","author":"Ye","year":"2024","journal-title":"Virol J"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s12072-024-10648-8","article-title":"Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-\u03b1: a systematic review and meta-analysis","volume":"18","author":"Jiang","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2021.104510","article-title":"The need to separate the wheat from the chaff in medical informatics: Introducing a comprehensive checklist for the (self)-assessment of medical AI studies","volume":"153","author":"Cabitza","year":"2021","journal-title":"Int. J. Med. Inf."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/JS9.0000000000001768","article-title":"Development of a staging system for hepatoid adenocarcinoma of the stomach based on multicenter data: a retrospective cohort study","volume":"111","author":"Huang","year":"2025","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0105","article-title":"Construction and evaluation of a mortality prediction model for patients with acute kidney injury undergoing continuous renal replacement therapy based on machine learning algorithms","volume":"56","author":"Wang","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110397","article-title":"Risk prediction models for successful discontinuation in acute kidney injury undergoing continuous renal replacement therapy","volume":"27","author":"Zhong","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0115","doi-asserted-by":"crossref","first-page":"e7374","DOI":"10.1002\/cam4.7374","article-title":"A clinical-radiomic-pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection","volume":"13","author":"Xie","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0120","article-title":"Six-gene prognostic signature for non-alcoholic fatty liver disease susceptibility using machine learning","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1243202","article-title":"A simple-to-use score system for predicting HBsAg clearance to peginterferon alfa-2b in nucleoside analogs-experienced chronic hepatitis B patients","volume":"10","author":"Song","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0130","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s12072-024-10666-6","article-title":"Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis","volume":"18","author":"Zhang","year":"2024","journal-title":"Hepatol Int."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1206720","article-title":"Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity","volume":"13","author":"Zheng","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105782","article-title":"Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy","volume":"221","author":"Zhao","year":"2024","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/1753425920942580","article-title":"Contribution of NK cells to HBsAg seroconversion in inactive HBsAg carriers following pegylated IFN therapy","volume":"26","author":"Cao","year":"2020","journal-title":"Innate Immun."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/HEP.0000000000000524","article-title":"Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-\u03b1 in patients with chronic hepatitis B","volume":"79","author":"Jiang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2019.08.024","article-title":"TNF-\u03b1\/IFN-\u03b3 profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection","volume":"72","author":"Wang","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(24)02160-3","article-title":"A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B","author":"Hur","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijmedinf.2025.105916_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102419","article-title":"Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study","volume":"68","author":"Rui","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0170","doi-asserted-by":"crossref","unstructured":"Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection, Gastroenterology 159 (2020) 652\u2013664. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.019.","DOI":"10.1053\/j.gastro.2020.04.019"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0175","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1136\/gutjnl-2021-324646","article-title":"Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection","volume":"71","author":"Aliabadi","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ijmedinf.2025.105916_b0180","article-title":"Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."}],"container-title":["International Journal of Medical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505625001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505625001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:36:03Z","timestamp":1762544163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386505625001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"alternative-id":["S1386505625001339"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2025.105916","relation":{},"ISSN":["1386-5056"],"issn-type":[{"value":"1386-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpretable machine learning model for prediction functional cure in chronic hepatitis B patients receiving Peg-IFN therapy: A multi-center study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2025.105916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105916"}}